Seth Harmon

Seth Harmon currently serves as Senior Vice President of Finance and Accounting at Viridian Therapeutics, Inc., a position held since May 2023. Prior to this, Seth held the role of CFO at BioNTech US and Vice President of Finance and Administration at BioNTech SE from May 2020 to May 2023. Additional experience includes serving as Vice President of Finance and Accounting at Neon Therapeutics from April 2017 to May 2020, Controller at Merrimack Pharmaceuticals from July 2014 to April 2017, and a Senior Manager in Assurance Practice at Ernst & Young from October 2003 to July 2014, specializing in the Retail and Consumer Products industry. Education includes a Master of Science in Accounting and Business from the D'Amore-McKim School of Business at Northeastern University and a Bachelor of Arts in Mathematics and Economics from Bowdoin College.